Funder
Japan Agency for Medical Research and Development
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Gazdar, A. F., Bunn, P. A. & Minna, J. D. Small-cell lung cancer: what we know, what we need to know and the path forward. Nat. Rev. Cancer. 17, 725–737 (2017).
2. Andersson, M. et al. Lung carcinoma and malignant mesothelioma in patients exposed to Thorotrast: incidence, histology and p53 status. Int. J. Cancer 63, 330–336 (1995).
3. Koinis, F., Kotsakis, A. & Georgoulias, V. Small cell lung cancer (SCLC): no treatment advances in recent years. Transl. Lung Cancer Res. 5, 39–50 (2016).
4. Sabari, J. K., Lok, B. H., Laird, J. H., Poirier, J. T. & Rudin, C. M. Unravelling the biology of SCLC: implications for therapy. Nat. Rev. Clin. Oncol. 14, 549–561 (2017).
5. Gazdar, A. F. & Minna, J. D. Developing new, rational therapies for recalcitrant small cell lung cancer. J. Natl, Cancer Inst. 108, 1–3 (2016).
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献